Terms: = Kidney tumors AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM AND Treatment
43 results:
1. Clinical experience of bench surgery combined with autotransplantation after three-dimensional laparoscopic nephrectomy for the treatment of highly complex renal tumor.
Xu Y; Huang J; Fan X; Wang Z; Lou J; Liu X; Weng G
World J Surg Oncol; 2023 Nov; 21(1):373. PubMed ID: 38031058
[TBL] [Abstract] [Full Text] [Related]
2. [treatment outcome of laparoscopic partial nephrectomy in patients with renal tumors of moderate to high complexity].
Qiu M; Zong YL; Wang BS; Yang B; Xu CX; Sun ZH; Lu M; Zhao L; Lu J; Liu C; Tian XJ; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):833-837. PubMed ID: 37807736
[TBL] [Abstract] [Full Text] [Related]
3. Nanocurcumin preserves kidney function and haematology parameters in DMBA-induced ovarian cancer treated with cisplatin via its antioxidative and anti-inflammatory effect in rats.
Louisa M; Wanafri E; Arozal W; Sandhiutami NMD; Basalamah AM
Pharm Biol; 2023 Dec; 61(1):298-305. PubMed ID: 36708211
[TBL] [Abstract] [Full Text] [Related]
4. The geriatric nutritional risk index predicts complications after nephrectomy for renal cancer.
Riveros C; Chalfant V; Bazargani S; Bandyk M; Balaji KC
Int Braz J Urol; 2023; 49(1):97-109. PubMed ID: 36512458
[TBL] [Abstract] [Full Text] [Related]
5. Association Between DPP4 Inhibitor Use and the Incidence of Cirrhosis, ESRD, and Some Cancers in Patients With Diabetes.
Na Y; Kim SW; Park IB; Choi SJ; Nam S; Jung J; Lee DH
J Clin Endocrinol Metab; 2022 Nov; 107(11):3022-3034. PubMed ID: 36108097
[TBL] [Abstract] [Full Text] [Related]
6. Health-related Quality of Life Analysis from KEYNOTE-426: Pembrolizumab plus Axitinib Versus Sunitinib for Advanced Renal Cell Carcinoma.
Bedke J; Rini BI; Plimack ER; Stus V; Gafanov R; Waddell T; Nosov D; Pouliot F; Soulières D; Melichar B; Vynnychenko I; Azevedo SJ; Borchiellini D; McDermott RS; Tamada S; Nguyen AM; Wan S; Perini RF; Rhoda Molife L; Atkins MB; Powles T
Eur Urol; 2022 Oct; 82(4):427-439. PubMed ID: 35843776
[TBL] [Abstract] [Full Text] [Related]
7. Differentiating Benign from Malignant Renal tumors Using T2- and Diffusion-Weighted Images: A Comparison of Deep Learning and Radiomics Models Versus Assessment from Radiologists.
Xu Q; Zhu Q; Liu H; Chang L; Duan S; Dou W; Li S; Ye J
J Magn Reson Imaging; 2022 Apr; 55(4):1251-1259. PubMed ID: 34462986
[TBL] [Abstract] [Full Text] [Related]
8. Cullin 4B regulates cell survival and apoptosis in clear cell renal cell carcinoma as a target of microRNA-217.
Yang HF; Wang ZL; Mao TT; Liu JC
Kaohsiung J Med Sci; 2021 Feb; 37(2):121-127. PubMed ID: 33022894
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological implications of the expression of vascular endothelial growth factor and programmed death ligand 1 in clear-cell renal cell carcinoma.
Lee KS; Yun S; Lee K; Moon S; Choe G
Hum Pathol; 2020 May; 99():88-97. PubMed ID: 32246989
[TBL] [Abstract] [Full Text] [Related]
10. Association of mTOR Pathway Markers and Clinical Outcomes in Patients with Intermediate-/High-risk Prostate Cancer: Long-Term Analysis.
Barata PC; Magi-Galluzzi C; Gupta R; Dreicer R; Klein EA; Garcia JA
Clin Genitourin Cancer; 2019 Oct; 17(5):366-372. PubMed ID: 31262501
[TBL] [Abstract] [Full Text] [Related]
11. Health-related quality of life of Brazilian children and adolescents with benign and malignant solid tumours: A prospective cohort study during the first year after hospital admission.
Coça KL; Bergmann A; Carrara de Angelis E; Ferman S; Ribeiro MG
Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13102. PubMed ID: 31184786
[TBL] [Abstract] [Full Text] [Related]
12. Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study.
Martínez Chanzá N; Xie W; Asim Bilen M; Dzimitrowicz H; Burkart J; Geynisman DM; Balakrishnan A; Bowman IA; Jain R; Stadler W; Zakharia Y; Narayan V; Beuselinck B; McKay RR; Tripathi A; Pachynski R; Hahn AW; Hsu J; Shah SA; Lam ET; Rose TL; Mega AE; Vogelzang N; Harrison MR; Mortazavi A; Plimack ER; Vaishampayan U; Hammers H; George S; Haas N; Agarwal N; Pal SK; Srinivas S; Carneiro BA; Heng DYC; Bosse D; Choueiri TK; Harshman LC
Lancet Oncol; 2019 Apr; 20(4):581-590. PubMed ID: 30827746
[TBL] [Abstract] [Full Text] [Related]
13. Baicalin induced colon cancer cells apoptosis through miR-217/DKK1-mediated inhibition of Wnt signaling pathway.
Jia Y; Chen L; Guo S; Li Y
Mol Biol Rep; 2019 Apr; 46(2):1693-1700. PubMed ID: 30737617
[TBL] [Abstract] [Full Text] [Related]
14. Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study.
Voss MH; Reising A; Cheng Y; Patel P; Marker M; Kuo F; Chan TA; Choueiri TK; Hsieh JJ; Hakimi AA; Motzer RJ
Lancet Oncol; 2018 Dec; 19(12):1688-1698. PubMed ID: 30416077
[TBL] [Abstract] [Full Text] [Related]
15. Abdominal organ position variation in children during image-guided radiotherapy.
Huijskens SC; van Dijk IWEM; Visser J; Balgobind BV; Te Lindert D; Rasch CRN; Alderliesten T; Bel A
Radiat Oncol; 2018 Sep; 13(1):173. PubMed ID: 30208936
[TBL] [Abstract] [Full Text] [Related]
16. Contribution of UGT1A1 genetic polymorphisms related to axitinib pharmacokinetics to safety and efficacy in patients with renal cell carcinoma.
Igarashi R; Inoue T; Fujiyama N; Tsuchiya N; Numakura K; Kagaya H; Saito M; Narita S; Satoh S; Niioka T; Miura M; Habuchi T
Med Oncol; 2018 Mar; 35(4):51. PubMed ID: 29524031
[TBL] [Abstract] [Full Text] [Related]
17. Role of WNT/β-Catenin Pathway as Potential Prognostic and Predictive Factors in Renal Cell Cancer Patients Treated With Everolimus in the Second and Subsequent Lines.
Bodnar L; Stec R; Cierniak S; Synowiec A; Wcisło G; Jesiotr M; Koktysz R; Chrom P; Szczylik C
Clin Genitourin Cancer; 2018 Aug; 16(4):257-265. PubMed ID: 29483043
[TBL] [Abstract] [Full Text] [Related]
18. Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805.
Jilaveanu LB; Puligandla M; Weiss SA; Wang XV; Zito C; Flaherty KT; Boeke M; Neumeister V; Camp RL; Adeniran A; Pins M; Manola J; DiPaola RS; Haas NB; Kluger HM
Clin Cancer Res; 2018 Jan; 24(1):217-223. PubMed ID: 29066509
[No Abstract] [Full Text] [Related]
19. Pazopanib as a second-line treatment for non-cytokine-treated metastatic renal cell carcinoma: a meta-analysis of the effect of treatment.
Kok VC; Kuo JT
BMC Urol; 2016 Jul; 16(1):34. PubMed ID: 27377922
[TBL] [Abstract] [Full Text] [Related]
20. Clinical Experience of Escalated Sunitinib Dose in Select Patients With Metastatic Renal Cell Carcinoma.
Shi HZ; Tian J; Chen X; Wang D; Li CL
Clin Genitourin Cancer; 2017 Feb; 15(1):139-144. PubMed ID: 27338518
[TBL] [Abstract] [Full Text] [Related]
[Next]
